Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond G Hill

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Journal of Clinical Pharmacology|November 22, 2019
Understanding the UK Psychoactive Substances ActRaymond G Hill
Lancet (London, England)|March 2, 2015
Bioscience industry: opportunities for early career researchersRaymond G Hill
Annual Review of Medicine|January 18, 2006
New treatments for neuropathic painAndrew S C Rice, Raymond G Hill
Idrugs : the Investigational Drugs Journal|July 28, 2006
Partnership between small biotech and big pharmaGregory J Wiederrecht, Raymond G Hill, Margaret S Beer
Trends in Pharmacological Sciences|February 7, 2002
CGRP receptors: a headache to study, but will antagonists prove therapeutic in migraine?Susan D Brain, David R Poyner, Raymond G Hill
Canadian Journal of Physiology and Pharmacology|May 25, 2002
The bradykinin B1 receptor antagonist B9858 inhibits a nociceptive spinal reflex in rabbitsGlenn S Mason, Michael J Cumberbatch, Raymond G Hill, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 26, 2002
Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculatureKevin R Oliver, Anna Wainwright, Lars Edvinsson, et al.
Pain|September 1, 1996
Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbilsNadia M J Rupniak, Emma Carlson, Susan Boyce, et al.
Translational Psychiatry|February 3, 2026
Task-related differences in network connectivity and dynamics in people with severe opioid use disorder compared with healthy controlsDanielle L Kurtin, Katherine Herlinger, Alexandra Hayes, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|November 22, 2019
Understanding the UK Psychoactive Substances ActRaymond G Hill
Lancet (London, England)|March 2, 2015
Bioscience industry: opportunities for early career researchersRaymond G Hill
Annual Review of Medicine|January 18, 2006
New treatments for neuropathic painAndrew S C Rice, Raymond G Hill
Idrugs : the Investigational Drugs Journal|July 28, 2006
Partnership between small biotech and big pharmaGregory J Wiederrecht, Raymond G Hill, Margaret S Beer
Trends in Pharmacological Sciences|February 7, 2002
CGRP receptors: a headache to study, but will antagonists prove therapeutic in migraine?Susan D Brain, David R Poyner, Raymond G Hill
Canadian Journal of Physiology and Pharmacology|May 25, 2002
The bradykinin B1 receptor antagonist B9858 inhibits a nociceptive spinal reflex in rabbitsGlenn S Mason, Michael J Cumberbatch, Raymond G Hill, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 26, 2002
Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculatureKevin R Oliver, Anna Wainwright, Lars Edvinsson, et al.
Pain|September 1, 1996
Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbilsNadia M J Rupniak, Emma Carlson, Susan Boyce, et al.
Translational Psychiatry|February 3, 2026
Task-related differences in network connectivity and dynamics in people with severe opioid use disorder compared with healthy controlsDanielle L Kurtin, Katherine Herlinger, Alexandra Hayes, et al.
Pageof 1